ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA)

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is focused on discovering and developing breakthrough medicines to treat cancer by regulating cell signaling with small molecules. The company has an exclusive license to pioneer technology and patents associated with certain NF-κB treatment methods, as well as the discovery and development of drugs to regulate NF-κB cell-signaling activity. These treatment methods and drugs could be useful in treating certain diseases. For further information, visit the Company’s web site at www.ariad.com.